Literature DB >> 12531876

Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations.

Jens Mogensen1, Toru Kubo, Mauricio Duque, William Uribe, Anthony Shaw, Ross Murphy, Juan R Gimeno, Perry Elliott, William J McKenna.   

Abstract

Restrictive cardiomyopathy (RCM) is an uncommon heart muscle disorder characterized by impaired filling of the ventricles with reduced volume in the presence of normal or near normal wall thickness and systolic function. The disease may be associated with systemic disease but is most often idiopathic. We recognized a large family in which individuals were affected by either idiopathic RCM or hypertrophic cardiomyopathy (HCM). Linkage analysis to selected sarcomeric contractile protein genes identified cardiac troponin I (TNNI3) as the likely disease gene. Subsequent mutation analysis revealed a novel missense mutation, which cosegregated with the disease in the family (lod score: 4.8). To determine if idiopathic RCM is part of the clinical expression of TNNI3 mutations, genetic investigations of the gene were performed in an additional nine unrelated RCM patients with restrictive filling patterns, bi-atrial dilatation, normal systolic function, and normal wall thickness. TNNI3 mutations were identified in six of these nine RCM patients. Two of the mutations identified in young individuals were de novo mutations. All mutations appeared in conserved and functionally important domains of the gene. This article was published online in advance of the print edition. The date of publication is available from the JCI website, http://www.jci.org.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12531876      PMCID: PMC151864          DOI: 10.1172/JCI16336

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

Review 1.  Ultrastructural features of hypertrophied human ventricular myocardium.

Authors:  B J Maron; V J Ferrans
Journal:  Prog Cardiovasc Dis       Date:  1978 Nov-Dec       Impact factor: 8.194

2.  Functional analysis of a troponin I (R145G) mutation associated with familial hypertrophic cardiomyopathy.

Authors:  Rosalyn Lang; Aldrin V Gomes; Jiaju Zhao; Philippe R Housmans; Todd Miller; James D Potter
Journal:  J Biol Chem       Date:  2002-01-18       Impact factor: 5.157

3.  Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy.

Authors:  A P Fitzpatrick; L M Shapiro; A F Rickards; P A Poole-Wilson
Journal:  Br Heart J       Date:  1990-02

4.  Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy.

Authors:  K Elliott; H Watkins; C S Redwood
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

5.  Deletion in the cardiac troponin I gene in a family from northern Sweden with hypertrophic cardiomyopathy.

Authors:  S Mörner; P Richard; E Kazzam; B Hainque; K Schwartz; A Waldenström
Journal:  J Mol Cell Cardiol       Date:  2000-03       Impact factor: 5.000

6.  The surgical pathology of hypertrophic cardiomyopathy.

Authors:  H D Tazelaar; M E Billingham
Journal:  Arch Pathol Lab Med       Date:  1987-03       Impact factor: 5.534

7.  Echocardiographic measurements in normal subjects. Growth-related changes that occur between infancy and early adulthood.

Authors:  W L Henry; J Ware; J M Gardin; S I Hepner; J McKay; M Weiner
Journal:  Circulation       Date:  1978-02       Impact factor: 29.690

8.  Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families.

Authors:  W J McKenna; P Spirito; M Desnos; O Dubourg; M Komajda
Journal:  Heart       Date:  1997-02       Impact factor: 5.994

9.  Echocardiographic measurements in normal subjects: evaluation of an adult population without clinically apparent heart disease.

Authors:  J M Gardin; W L Henry; D D Savage; J H Ware; C Burn; J S Borer
Journal:  J Clin Ultrasound       Date:  1979-12       Impact factor: 0.910

10.  Idiopathic restrictive cardiomyopathy.

Authors:  R J Siegel; P K Shah; M C Fishbein
Journal:  Circulation       Date:  1984-08       Impact factor: 29.690

View more
  113 in total

1.  Genotype, phenotype: upstairs, downstairs in the family of cardiomyopathies.

Authors:  Kenneth R Chien
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

2.  Diastolic dysfunction and thin filament dysregulation resulting from excitation-contraction uncoupling in a mouse model of restrictive cardiomyopathy.

Authors:  Jennifer Davis; Soichiro Yasuda; Nathan J Palpant; Joshua Martindale; Tamara Stevenson; Kimber Converso; Joseph M Metzger
Journal:  J Mol Cell Cardiol       Date:  2012-06-06       Impact factor: 5.000

Review 3.  Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all.

Authors:  Thomas E Callis; Brian C Jensen; Karen E Weck; Monte S Willis
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

4.  Application of Whole Exome Sequencing in the Clinical Diagnosis and Management of Inherited Cardiovascular Diseases in Adults.

Authors:  Sara B Seidelmann; Emily Smith; Lakshman Subrahmanyan; Daniel Dykas; Maen D Abou Ziki; Bani Azari; Fady Hannah-Shmouni; Yuexin Jiang; Joseph G Akar; Mark Marieb; Daniel Jacoby; Allen E Bale; Richard P Lifton; Arya Mani
Journal:  Circ Cardiovasc Genet       Date:  2017-02

Review 5.  Structural based insights into the role of troponin in cardiac muscle pathophysiology.

Authors:  Monica X Li; Xu Wang; Brian D Sykes
Journal:  J Muscle Res Cell Motil       Date:  2005-02-09       Impact factor: 2.698

Review 6.  Beta-adrenergic receptors signaling and heart failure in mice, rabbits and humans.

Authors:  A J Marian
Journal:  J Mol Cell Cardiol       Date:  2006-05-23       Impact factor: 5.000

7.  Novel Mutation in FLNC (Filamin C) Causes Familial Restrictive Cardiomyopathy.

Authors:  Nathan R Tucker; Micheal A McLellan; Dongjian Hu; Jiangchuan Ye; Victoria A Parsons; Robert W Mills; Sebastian Clauss; Elena Dolmatova; Marisa A Shea; David J Milan; Nandita S Scott; Mark Lindsay; Steven A Lubitz; Ibrahim J Domian; James R Stone; Honghuang Lin; Patrick T Ellinor
Journal:  Circ Cardiovasc Genet       Date:  2017-12

Review 8.  Mendelian forms of structural cardiovascular disease.

Authors:  Calum A MacRae
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

9.  Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy.

Authors:  Taranjit Singh Rai; Shamim Ahmad; Ajay Bahl; Monica Ahuja; Tarunveer Singh Ahluwalia; Balvinder Singh; K K Talwar; Madhu Khullar
Journal:  Mol Cell Biochem       Date:  2008-10-25       Impact factor: 3.396

10.  Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.

Authors:  J Malcom; O Arnold; Jonathan G Howlett; Anique Ducharme; Justin A Ezekowitz; Martin J Gardner; Nadia Giannetti; Haissam Haddad; George A Heckman; Debra Isaac; Philip Jong; Peter Liu; Elizabeth Mann; Robert S McKelvie; Gordon W Moe; Anna M Svendsen; Ross T Tsuyuki; Kelly O'Halloran; Heather J Ross; Errol J Sequeira; Michel White
Journal:  Can J Cardiol       Date:  2008-01       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.